| |
|
|
|
Endra Life Sciences Inc  
|
|
1.865 -0.265 (-0.12%) |
03-05 10:37 |
|
Open: |
2.08 |
Pre close: |
2.13 |
Target:
|
2.92
|
|
High: |
2.13 |
Low: |
1.86 |
Resistance:
|
2.50
3.05
|
|
Volume: |
991,573 |
Market Cap: |
70M |
Support:
|
1.60
1.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.39
 |
MACD |
MACD(12,26):
|
0.11 |
|
MA(20): |
2.38 |
Signal(12,26,9): |
0.18 |
|
MA(100): |
1.29  |
Stochastic Oscillator |
%K(14,3):
|
43.45 |
|
MA(250): |
1.02 |
%D(3): |
56.51 |
|
Average Volume(K) |
3-Month: |
307648
|
52-Week |
High:
|
3.05 |
|
10-Days: |
275167 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
46.99 |
Change(%): |
96.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.955 |
Return on Equity (ttm) |
-603.0 |
Shares Out. (M) |
32.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-172.4 |
Shares Float (M) |
22.67 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.48 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.79 |
|
Forward EPS |
-2.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
494 |
|
Book Value (p.s.) |
0.130 |
EBITDA (p.s.) |
-0.373 |
P/E |
-2.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
16.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.07 |
P/CF |
-6.54 |
|
|
|
|
|
|
